YUTIQ is designed to
deliver treatment for
up to 36 months
See an innovation in uveitis treatment. YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg is designed to provide lasting treatment up to 36 months so you can see everything you want to see. YUTIQ is a single-injection treatment for patients with chronic non-infectious uveitis affecting the back of the eye (posterior segment).
YUTIQ is designed to deliver treatment for up to 36 months, providing continuous calm with less inflammation. You may also have fewer injection appointments.
If you have any uveitis symptoms, find a retina or uveitis specialist near you to talk to, or ask your eye doctor if treatment with YUTIQ would be right for you.
Do not take YUTIQ if:
This site is intended for US residents only. YUTIQ is a registered trademark of Alimera Sciences, Inc.
CONTINUOUS CALM and CONTINUOUS MICRODOSING are trademarks of Alimera Sciences, Inc.
https://preventblindness.org/wp-content/uploads/2021/06/FS119-Uveitisshort.pdf